Protyon

Groningen, Netherlands Founded: 2022 • Age: 4 yrs
Cancer therapeutics development and training programs are provided.
Request Access

About Protyon

Protyon is a company based in Groningen (Netherlands) founded in 2022 by Rositsa Jordanova, Josef Melcr, and Hoang Nguyen.. Protyon has raised $658.29 thousand across 1 funding round from investors including NVNOM and LUMO Labs. Protyon offers products and services including 3D Digital Model and Training Course. Protyon operates in a competitive market with competitors including GenomOncology, ONCOHOST, Geneseeq, Radialogica and Sipai Wangluo, among others.

  • Headquarter Groningen, Netherlands
  • Founders Rositsa Jordanova, Josef Melcr, Hoang Nguyen
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Protyon Bv
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $658.29 K (USD)

    in 1 rounds

  • Latest Funding Round
    $658.29 K (USD), Seed

    May 11, 2023

  • Investors
    NVNOM

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Protyon

Protyon offers a comprehensive portfolio of products and services, including 3D Digital Model and Training Course. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Predicts interactions of drugs with cancer mutations for therapy selection.

Teaches clinicians molecular modeling for cancer treatment decisions.

Funding Insights of Protyon

Protyon has successfully raised a total of $658.29K through 1 strategic funding round. The most recent funding activity was a Seed round of $658.29 thousand completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $658,290
  • First Round

    (11 May 2023)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2023 Amount Seed - Protyon Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Protyon

Protyon has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include NVNOM and LUMO Labs. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Opportunities are created for impact-driven ventures in emerging technologies.
Founded Year Domain Location
Management consulting and business management services are provided to clients.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Protyon

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Protyon

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Protyon Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Protyon

Protyon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenomOncology, ONCOHOST, Geneseeq, Radialogica and Sipai Wangluo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genomic data is transformed into actionable insights for precision medicine.
domain founded_year HQ Location
AI-based proteomic analysis for oncology therapy planning is offered.
domain founded_year HQ Location
Personalized cancer treatments are delivered using genomic RNA profiling.
domain founded_year HQ Location
Decision support tools for radiation oncology are provided to clinicians.
domain founded_year HQ Location
Delivers big data aggregation and analytics solutions for oncology.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Protyon

Frequently Asked Questions about Protyon

When was Protyon founded?

Protyon was founded in 2022 and raised its 1st funding round 1 year after it was founded.

Where is Protyon located?

Protyon is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.

Who is the current CEO of Protyon?

Rositsa Jordanova is the current CEO of Protyon. They have also founded this company.

Is Protyon a funded company?

Protyon is a funded company, having raised a total of $658.29K across 1 funding round to date. The company's 1st funding round was a Seed of $658.29K, raised on May 11, 2023.

What does Protyon do?

Protyon was established in 2022 in Groningen, Netherlands. Operations are focused on the biotechnology sector, where cancer therapeutics are developed through research and innovation processes. Training programs are offered to support professional development in oncology-related fields. Services encompass both therapeutic advancement and educational initiatives, with activities centered in the European healthcare landscape. Key leadership includes co-founders handling CEO, CTO, and CCO roles.

Who are the top competitors of Protyon?

Protyon's top competitors include ONCOHOST, GenomOncology and Geneseeq.

What products or services does Protyon offer?

Protyon offers 3D Digital Model and Training Course.

Who are Protyon's investors?

Protyon has 2 investors. Key investors include NVNOM, and LUMO Labs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available